达普托米辛治疗儿科复杂骨关节感染:来自三年研究的现实有效性和安全性数据
Marco Denina1, Giulia Abrate2, Erika Silvestro1
1From the Department of Pediatrics, Infectious Diseases Unit, University of Turin, Regina Margherita Children's Hospital, Turin, Italy.
The Pediatric infectious disease journal
|March 19, 2025
概括
达普托米辛在治疗复杂的儿科骨和关节感染方面取得了很高的成功,包括那些由耐美西林黄金葡萄球菌 (MRSA) 引起的感染. 这种抗生素是安全有效的,表明其作为一线治疗选择的潜力.
科学领域:
- 儿童传染病 儿童传染病
- 药理学 药理学是指药理学的学科.
- 整形外科 整形外科 整形外科
背景情况:
- 儿童的骨和关节感染带来了治疗挑战,通常是由金黄色葡萄球菌引起的.
- 耐甲基西林黄金葡萄球菌 (MRSA) 需要对敏感和耐药菌株有效的抗生素.
- 达普托米辛是一种越来越多地用于治疗儿科骨髓炎的非标签抗生素.
研究的目的:
- 评估达普素在儿童骨关节感染中的实际应用,临床结果,剂量,安全性和治疗潜力.
- 为了评估daptomycin在患有并发症的复杂儿科患者队列中的疗效.
- 分析微生物景观和治疗成功率.
主要方法:
- 长达3年的前性研究,涉及20名患有骨关节感染的儿科患者,这些患者接受了达普素治疗.
- 达普托米辛按细菌病的剂量指南使用,有些人服用更高的剂量 (平均10毫克/公斤).
- 通过C-反应蛋白水平,继续治疗,需要手术和不良事件评估临床结果.
主要成果:
- 在复杂的儿科队列中,治疗成功率为90% (伴随疾病的70%).
- 对于对甲素敏感的金黄色葡萄球菌 (60%) 和MRSA (35%) 均有效.
- 没有严重的不良事件;在2例病例中观察到过渡性中性质减退和肌酸激酶升高.
结论:
- 达普托米辛在复杂的儿科骨关节感染中显示出安全性和有效性.
- 表明作为一线治疗的潜力,特别是对MRSA感染.
- 支持重新考虑在儿科骨关节感染的初始治疗方案中使用达普素.
相关概念视频
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...